Benitec Biopharma will participate in investor conferences on December 4 and December 12, 2024, in New York.Quiver AI SummaryBenitec Biopharma Inc., a biotechnology company based in Hayward, California,...
CAPITAL MANAGEMENT, LLC SUVRETTA, a director at $BNTC ($BNTC), bought 12,430 shares of the company on 11-19-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This...
Benitec Biopharma reports promising interim results from BB-301 clinical trials for dysphagia, with ongoing patient enrollment and treatments.Quiver AI SummaryBenitec Biopharma Inc. announced positive...
A renewed fight against COVID-19 might be coming.
Benitec Biopharma Inc. (NASDAQ: BNTC), a leader in gene therapy, has announced that the U.S. Food and Drug Administration (FDA)